San Francisco-based Clover Health, a health care technology company and Medicare Advantage insurer, has launched an in-home primary care program that will include gene testing for medication management.
The program, which already has approximately 500 members in New Jersey, uses genomic testing integration capabilities from YouScript, a clinical decision support tool for medication management. Clover serves members in Georgia, Texas, Pennsylvania and New Jersey.
The in-home primary care program will focus on reducing hospital readmissions among the plan’s sickest members, leveraging a physician-led team of PCPs, nurses, social workers, medical assistants and care coordinators for members in the home.
“Our main focus as a company is to improve the quality of life for each and every Clover member and physician,” Vivek Garipalli, co-founder and CEO of Clover, said in a statement. “We are constantly identifying new ways to improve member outcomes using new data streams and advanced models of care. Our in-home care program combines our expertise as a data and technology company with our ongoing joint desire to bring access and care directly to those most in need.”
The announcement comes as other major Medicare Advantage plans are aggressively entering the in-home care space. Lousiville-based Humana (NYSE: HUM), the nation’s second-largest MA insurance provider, is in the midst of acquiring the home health and hospice services of Kindred Healthcare (NYSE: KND) with its private equity partners.
Enrollment for Clover’s in-home care program is voluntary and free to members. Clover will perform pharmacogenomic testing to personalize each member’s drug regimen, according to the company.
The services in the program include regularly scheduled personal check-ins, active monitoring and home-based lab and radiology testing, delivered to homebound patients. Clover care teams are assigned a “small panel of members and are exclusive,” and the company collaborates with its in-network physicians to identify members suited for the program.
“Our No. 1 priority is to provide exceptional in-home primary care, and we’ve built a multidisciplinary team of health care professionals who are responsive 24/7 to achieve this goal,” Kumar Dharmarajan, MD, chief scientific officer at Clover and a practicing geriatrician, said in a statement. “To do this, we are using data, technology and care innovations to further improve our members’ lives.”
Written by Amy Baxter